Image 01
Mesalamine Capsule, Extended Release
Product Images NDC 68682-113
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 68682-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
This is a description of Mesalamine Extended-Release Capsules, a prescription medication for the treatment of inflammatory bowel disease. The capsules come in a quantity of 120 and each contains 0.375g of mesalamine. The package insert contains full prescribing information, including dosages. The medication should be kept out of reach of children and should be stored at a controlled room temperature (20°C to 25°C). The product is manufactured in Canada and there is patent information available in the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
